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There is an urgent need for rapid, reliable, and cost-effec-tive methods to monitor patients who are at high risk for 
adverse vascular events. Such methods may be used to target 
treatment to high-risk patients, thereby preventing vascular 
events.1 Ultrasound is a relatively inexpensive and widely 
available imaging method enabling quantitative imaging mea-
surements of the carotid artery wall, including intima-media 
thickness, vessel wall volume, and plaque burden. It has been 
shown that carotid plaque burden measures, such as total 
plaque area or total plaque volume (TPV) and their changes 
over time, provide strong predictors of adverse events.2
Carotid ultrasound, by means of plaque echogenicity or 
texture, also provides a way to measure plaque composi-
tion. Lipid cores and intraplaque hemorrhage are thought to 
destabilize plaque, whereas calcifications have a stabilizing 
effect.3,4 In ultrasound, lipid and hemorrhagic areas are more 
echolucent, whereas calcified and fibrous areas are echorich.5 
Ultrasound echogenicity has been shown to differentiate 
between symptomatic and asymptomatic subjects6 and has 
been used to predict events.7–9 More complex texture mea-
sures, with examples given in Table I in the online-only Data 
Supplement, provide information on the distribution of pixel 
intensities over the plaque. Incorporating such higher order 
texture parameters, such as coarseness or contrast, may pro-
vide more insight into the underlying tissue properties and 
has been used in several studies as well.10–12 In previous stud-
ies, these higher order texture measures were shown to dif-
ferentiate accurately between symptomatic and asymptomatic 
subjects10 and performed better than a set of plaque shape 
parameters.11 In addition, they were more predictive of events 
than a combination of a history of events and plaque param-
eters, such as plaque area and gray scale median.12
In addition to single time-point measurements, progres-
sion of TPV was shown to be a strong predictor of events,2 
and changes in plaque texture were more sensitive to statin-
induced effects than changes in TPV.13 On the basis of all 
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these findings, we hypothesized that changes in plaque com-
position over time may be related to subsequent vascular 
events. Therefore, here our goal is to develop 3-dimensional 
ultrasound (3DUS) plaque texture measurements and to deter-
mine whether plaque texture and changes in plaque texture 
could improve the prediction of events in high-risk patients.
Methods
Study population, image acquisition and plaque volume annotation 
have previously been described.2,14
Study Population
Patients with a history of risk factors, such as hypertension or hy-
perlipidemia, or with a history of vascular events, who were be-
ing followed up in the Stroke Prevention Clinic or the Premature 
Atherosclerosis Clinic at the University Hospital, London, Canada, 
were enrolled in the study. The inclusion criteria included a baseline 
plaque area between 40 and 600 mm2, measured by 2D ultrasound.15 
All plaques from the clavicle to the angle of the jaw, including the 
right subclavian artery and the common, internal and external carotid 
artery were considered. Participants with a stenosis ≥70% on Doppler 
ultrasound were excluded, and all subjects provided written informed 
consent to a protocol approved by the Western University Human 
Research Ethics Board.
Follow-Up for Outcomes
Participants were followed up for ≤5 years (median [range], 3.12 
[0.77–4.66]). At each annual visit, participants were queried about 
any events in the previous year. Any report of stroke, transient isch-
emic attack (TIA), or myocardial infarction (MI) was confirmed by 
review of the hospital electronic record. For patients who could not 
be contacted to attend for follow-up because they had died, death 
and cause of death were confirmed by contact with the primary care 
physician. The sonographer who evaluated the images was blinded 
with respect to events.
Ultrasound Acquisition
3DUS scans (most common voxel size, 0.21×0.21×0.21 mm; mean, 
0.21×0.21×0.33 mm) of both carotid arteries were acquired at base-
line and after 1 year (median [range], 364 [226–897] days). The ultra-
sound transducer (L12-5; 50 mm; Philips, Bothel, WA) was manually 
moved along the neck of the patient for 4.0 cm in ≈8 s, imaging ≈30 
slices/s, centered around the bifurcation. Video frames were digitized 
using 3DEchotec equipment (General Electric Medical Systems, 
Hallbergmoos, Germany). The acquired 2D images were reconstruct-
ed immediately into a 3DUS image (3DQuantify; Robarts Research 
Institute, London, Canada). It was attempted that the same technician 
made the baseline and follow-up scan of each patient.
TPV Assessment
For plaque delineation, the 3DUS image was displayed using 
3DQuantify. TPV was measured as described previously16 in all scans 
by 1 observer (T.W.) who was blinded to the time-point (baseline or 
follow-up), patient characteristics, and vascular events. All plaques 
between 1.5 cm below the bifurcation and 1.0 cm above the bifurca-
tion into the internal carotid artery were considered. For each plaque, 
a plane in the longitudinal view which best visualized the plaque was 
selected for defining the length of the plaque and for placing 2 end 
points at the proximal and distal ends of the plaque. At 25%, 50%, 
and 75% of its length, the boundary of the plaque was annotated per-
pendicular to the long axis. These boundaries and the end points were 
connected by a computer program to create a volume. TPV per pa-
tient was measured as the sum of the volume of all plaques present.
For reference, intima-media thickness was measured from longi-
tudinal image planes extracted from the 3DUS images as previously 
described,2,17 and repeated 3× per image.
Texture Analysis
A set of 376 texture measures based on 9 different texture extraction 
techniques was calculated. Most of the texture measures have previ-
ously been used in studies on 2D10–12 and 3D13 carotid ultrasound. An 
overview is provided in Table 1 (details can be found in the online-
only Data Supplement).
Texture was calculated for the annotated plaque volumes in both 
arteries. For each measure, the average was calculated by weighting 
the values per plaque by the plaque volumes, to obtain 1 value per 
patient for each measure, at both baseline and follow-up. For 7 cases 
with no plaque in the 3D ultrasound at baseline, baseline texture was 
taken as the mean of all other subjects at baseline. Texture measures 
were normalized by setting the mean of all subjects to 0 with a SD of 
1 for each measure.
Sparse Cox regression was used to combine the 376 texture mea-
sures into 1 texture-based risk indicator, using the glmnet toolbox27,28 
for R29. With sparse regression, a penalty term promotes the reduction 
of the number of parameters in the model, leaving only the strongest 
predictors. In our experiments, we fixed the number of remaining pa-
rameters in the model to 5 because of the relatively low number of 
events.
To ensure unbiased parameter selection, experiments were per-
formed by 10-fold cross-validation, so subjects were randomly di-
vided in 10 equally sized groups with the event incidence equally 
divided over those 10-folds. Within cross-validation experiments 
the model for combining texture measures was built on 9 of the 
10-folds, and used to calculate the hazard ratio (HR) for the sub-
jects in the 10th-fold. This was repeated 10× with each fold left out 
once, to obtain an HR for each subject. This HR was used as the 
texture-based risk indicator. This was performed both for the 376 
baseline texture parameters and for the 376 texture change param-
eters, which were calculated by subtracting baseline texture from 
follow-up texture.
To combine ≥2 parameters (texture/TPV baseline/changes), a Cox 
model was built using only those parameters. This was done using 
the same 10-fold cross-validation: both the model to combine the 
texture measures into 1 risk parameter, and the model to combine 
parameters was developed on 9 folds and evaluated on the 10th. All 
cross-validation experiments were repeated 5×, to evaluate stability 
of the procedure.
Statistical Analysis
Because of non-normality of the studied parameters, continuous vari-
ables are given as median and interquartile range, and Kruskal–Wallis 
testing was used to test for differences between groups. For categori-
cal variables, a χ2 test was used to compare groups.
The predictive value of the studied parameters was evaluated by 
receiver-operating characteristic (ROC) analysis, Kaplan–Meier 
analysis, and multivariate Cox regression. For ROC analysis, the area 
under the curve was determined for baseline texture, texture change, 
baseline TPV and TPV change, and combinations of those measures. 
Further analyses focused on texture change and TPV change, and 
Table 1. Texture Measures Used in the Analysis
Method No. of Features
Gray-level distribution13 34
Gray-level co-occurrence matrix18 78
Gray-level run length matrix19 60
Gray-level difference matrix20 12
Neighborhood gray-tone difference matrix21 10
Law’s texture22 105
Local binary pattern23 27
Gaussian filter bank24 24
Structure tensor25,26 20
A more detailed description can be found in the online-only Data Supplement.
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their combination. Kaplan–Meier curves were made after dividing the 
participants in 3 equally sized groups of increasing TPV or texture 
change (HR). The differences between these groups were tested for 
statistical significance by log-rank tests. In addition, the HR of the 
high-risk group with respect to the other 2 groups was determined by 
Cox regression.
To evaluate the potential effects of the ultrasound-derived mea-
sures in combination with other covariates, Cox regression was 
performed with change in TPV, change in plaque texture, and the 
extended Framingham risk score.30 The extended Framingham 
risk score predicts general cardiovascular disease risk, based on 
age, sex, high-density lipoprotein and total cholesterol, systolic 
blood pressure (treated or untreated), smoking, and diabetes mel-
litus. Because of skewness of the texture measure, the logarithm 
of this measure was used. The full model was compared with 
the model without texture change, and the model without TPV 
change, using a log-likelihood ratio test. In addition, Cox regres-
sion was performed using a stepwise backward Wald approach, 
with baseline TPV and texture added as covariates to verify their 
predictive value in combination with plaque changes and clinical 
parameters.
In all experiments, participants who experienced MI, TIA, or 
stroke during follow-up were considered as positive for vascular 
events. Statistical analysis was performed using both R (Sparse Cox 
regression, ROC, and Kaplan–Meier analysis) and SPSS software 
(full Cox regression models).
Results
Patient Characteristics
In total, 298 patients were included for 3DUS analysis. During 
follow-up, 27 of these subjects experienced a vascular event, 
of which 9 had a stroke, 11 a TIA, and 7 a MI. Two subjects 
died as a consequence of the event. Baseline characteristics 
are provided in Table 2.
Texture Measures
In Figure 1, 2 of the strongest texture measures (when consid-
ering texture change) are shown for a single patient. These 2 
measures were most often selected by Cox regression, 49 and 
48 of 50 experiments, respectively. The 2 plaques in this vessel 
are different in appearance, which is reflected by the 2 texture 
images. Table I in the online-only Data Supplement provides 
the 6 most often selected texture measures as selected by sparse 
Cox regression, alongside with texture change and TPV change, 
and their values in patients who do or do not experience a vascu-
lar event for reference. In practice, only these strongest texture 
parameters need to be calculated, on which the risk parameter 
can be determined and compared with reference values.
Table 2. Baseline Characteristics
Without Event (n=271)* With Event (n=27)* P Value†
Age, y 70 (64–77) 75 (64–80) 0.30
Men, % 58 52 0.54
Systolic blood pressure, mm Hg 134 (122–149) 131 (114–142) 0.11
Diastolic blood pressure, mm Hg 74 (66–82) 69 (62–78) 0.17
IMT, mm 0.92 (0.82–1.04) 0.93 (0.84–0.98) 0.74
TPV, mm3 273 (191–437) 253 (119–422) 0.21
Stenosis, % 40 (40–50) 40 (40–40) 0.26
BMI 27.9 (25.5–31.5) 29.0 (25.3–31.8) 0.96
Smoking (never, quit, and still smoking) 36%, 56%, and 8% 33%, 48%, and 19% 0.74, 0.45, and 0.06
Smoking pack-years 5 (0–24) 15 (0–28) 0.34
Total cholesterol, mmol/L 3.9 (3.4–4.7) 4.1 (3.5–4.9) 0.35
HDL cholesterol, mmol/L 1.3 (1.1–1.7) 1.3 (1.1–1.8) 0.85
LDL cholesterol, mmol/L 1.9 (1.5–2.5) 2.1 (1.5–2.6) 0.30
Triglycerides, mmol/L 1.2 (0.9–1.7) 1.1 (0.9–1.8) 0.77
Framingham risk score 16 (13–18) 15 (13–19) 0.61
Diabetes mellitus, % 21 19 0.79
Previous stroke, % 22 33 0.19
Previous TIA, % 42 56 0.18
Previous MI, % 14 26 0.11
Previous atrial fibrillation, % 9 15 0.31
Previous endarterectomy, % 7 4 0.48
Previous carotid angioplasty, % 1 4 0.26
Previous peripheral artery angioplasty, % 1 4 0.26
Previous coronary angioplasty, % 7 11 0.44
CABG, % 10 15 0.47
Taking antihypertensive drug, % 89 93 0.52
BMI indicates body mass index; CABG, coronary artery bypass graft; HDL, high-density lipoprotein; IMT, intima-media 
thickness; LDL, low-density lipoprotein; MI, myocardial infarction; TIA, transient ischemic attack; and TPV, total plaque 
volume.
*Continuous variables are given as median (interquartile range); categorical variables are given as percentages.
†P values using Kruskal–Wallis testing for continuous variables and χ2 testing for categorical variables.
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ROC Analysis
In Figure 2A, ROC curves are shown for baseline TPV and 
texture and change in intima-media thickness, TPV, and 
texture. Figure 2B shows ROC curves when ≥2 features are 
combined.
Kaplan–Meier Analysis
Figure 3 shows Kaplan–Meier curves for TPV change, texture 
change, and their combination. Threshold values of the HRs 
for separating the medium-risk tertile from the low-risk and 
high-risk tertiles were −21 and 59 mm3 for TPV change, 0.9 
and 1.1 for texture change, and 0.7 and 1.3 for their combina-
tion. The difference between risk tertiles was significant for 
all experiments (P=0.039 for TPV change; P≤0.01 for texture 
change; and P<0.001 for the combination).
Comparing the high-risk tertile with the combined low-risk 
and medium-risk tertiles with Cox regression, showed a HR 
of 2.3 (P=0.03) for TPV change, 4.3 (2.7–6.4) with P<0.001 
to 0.01 for texture change, and 6.2 (4.2–7.9) with P<0.001 for 
the combination.
Cox Regression
Table 3 shows the results for Cox regression with TPV change, 
texture change, and the Framingham risk score. Both TPV 
change and texture change were significant predictors of stroke, 
TIA, and MI, whereas in this data set the Framingham risk score 
was not. The log-likelihood ratio tests indicated that the full 
model was significantly better than the model excluding texture 
change and the model excluding TPV change (all P<0.01).
Table II in the online-only Data Supplement shows 3 addi-
tional subanalyses. When only stroke and TIA are considered 
as events, TPV change (HR, 1.5; P≤0.007) and texture change 
(HR, 1.4; P≤0.003) remain the only significant parameters 
in the model. Moreover, after exclusion of 7 patients with-
out plaque at the 3DUS baseline image (TPV change: HR, 
1.5; P≤0.001 and texture change: HR, 1.6; P≤0.001) and after 
exclusion of 28 patients with atrial fibrillation at baseline 
(TPV change: HR, 1.7; P<0.001 and texture change: HR, 1.5; 
P≤0.003), results were similar as well.
Figure 2. Receiver-operating characteristic curves for the prediction of vascular events. Black bars represent the SE of the 5 repetitions. 
A, Area under the curve (AUC) is 0.57 for baseline (BL) total plaque volume (TPV), 0.68±0.01 for BL texture, 0.57 for intima-media thick-
ness (IMT) change, 0.72 for TPV change, and 0.74±0.02 for texture change. B, AUC is 0.71±0.02 for the combination of BL TPV and 
TPV change, 0.75±0.03 for BL texture and texture change, 0.66±0.02 for BL texture and TPV, 0.78±0.02 for texture and TPV change, 
0.78±0.01 for BL texture and TPV change, 0.79±0.02 for BL texture and texture and TPV change, and 0.78±0.02 for all 4 parameters: BL 
texture and TPV and texture and TPV change. Δ indicates change.
Figure 1. Texture for 2 plaques in the same vessel with a differ-
ent appearance. In a total of 50 runs of sparse Cox regression 
(5× 10-fold cross-validation) on changes in texture, Laws edge-
edge-ripple (EER) was selected in the model 49 times, and laws 
spot-spot-ripple (SSR) 48 times.
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For backward Wald analysis, including baseline TPV, base-
line texture, TPV change, texture change, and the Framingham 
risk score in all 5 experiments, TPV change (P≤0.001; HR, 
1.4–1.5) and texture change (P≤0.003; HR, 1.3–1.5) were the 
only 2 remaining parameters.
Discussion
This study compared the predictive value for vascular events 
of texture and TPV derived from 3D carotid ultrasound. 
Changes in 3DUS texture characteristics and TPV over time 
were stronger predictors than baseline variables. Both texture 
and TPV change remained significant predictors after adjust-
ment for the Framingham risk score. The full model was sig-
nificantly better than the model including only TPV or texture 
change and the Framingham risk score.
The predictive value of TPV change over time2 and baseline 
texture12 have been evaluated previously, but to our knowledge 
this is the first study to consider changes in texture and to 
combine texture change and TPV change for risk stratifica-
tion of patients over time. Texture change was more predictive 
of events than baseline texture, which suggests that plaques 
that are changing faster impose a higher risk on patients than 
plaques that are stable in texture and by analogy, stable in 
composition. This notion is also supported by the observa-
tion that in our analysis, for all texture measures that were 
selected, the median change is closer to zero for patients not 
experiencing an event than for those who do (Table I in the 
online-only Data Supplement). Moreover, this is analogous to 
recent findings that plaque changes, such as TPV progression2 
or fastest intima-media thickness progression over several 
vessel segments,31 are predictive of events.
Framingham risk score was not predictive of events in this 
data set. This could be explained by the inclusion that was 
based on the presence of carotid plaque and risk factors or 
symptoms. All included patients had an increased Framingham 
risk score (interquartile range, 13–18). Here, we show that in 
a population with increased risk, plaque measurements using 
ultrasound can further stratify patients.
In a previous study where statin-induced changes were bet-
ter reflected by texture change than by TPV change,13 Law’s 
texture measures performed best, which is similar to our find-
ings. Moreover, neighborhood gray-tone difference matrix 
coarseness was important in our study and was among the 
best measures in previous work that showed the discrimina-
tion between symptomatic and asymptomatic patients.11
Our findings can be used both for patient monitoring and 
evaluation of therapies. The present study shows that includ-
ing plaque texture in the monitoring of patients contributes to 
improved risk assessment using ultrasound. A yearly follow-
up, including ultrasound in an atherosclerosis clinic, is practi-
cally feasible.32 More regular follow-up of high-risk patients 
would be possible to enable adjustment of therapy in a more 
timely fashion. Adjusting patient treatment based on changes 
in plaque area instead of traditional risk factors was already 
shown to reduce the number of vascular events significantly.33 
Including changes in TPV and texture could further improve 
effectiveness of patient management. In addition, cost-effec-
tive measurements are needed to evaluate newly developed 
Figure 3. Kaplan–Meier curves of event-free survival for 3 tertiles 
for (A) total plaque volume (TPV) change, (B) texture change, and 
(C) the combination of TPV and texture change. The number of 
events per tertile, as median (range), is given for the 3 different 
models. For all 3 methods, the difference between tertiles is sig-
nificant: P=0.039 for TPV change, P≤0.01 for texture change, and 
P<0.001 for the combination of TPV change and texture change.
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therapies, where imaging parameters will be a good secondary 
end point as an alternative to the number of events for which 
larger studies and longer follow-up are required.
When MI was left out as an end point, no relevant changes in 
the HR of both texture change and TPV change were observed 
in Cox regression. The number of MIs was too small to study 
the effect for MI only, but these findings are supported by the 
notion that vascular disease is systemic, and that carotid ath-
erosclerosis may estimate and reflect disease in other vessels 
accurately.34,35
A limitation of this study is the relatively small number 
of events. However, the finding that TPV change and texture 
change are both significant predictors of events even in this 
relatively small data set supports the use of such ultrasound-
derived measures when compared with traditional risk factors. 
It should be noted that these results hold only for subjects with 
identified carotid atherosclerosis, which is a clinically relevant 
population. In addition, the sensitivity of the proposed method 
to the used imaging equipment and settings has to be evalu-
ated. Finally, it is important to acknowledge that to incor-
porate plaque texture into clinical practice and large clinical 
studies, automated analysis will be required. In the present 
study, plaque volumes were segmented semiautomatically, as 
described previously,16 but automatic methods are also avail-
able,36 which will help facilitate translation to clinical practice.
Conclusions
Changes in ultrasound plaque texture and volume are predic-
tors of vascular events in patients in whom traditional risk fac-
tors measured by the Framingham risk score are not. These 
measures can be used in clinical practice as a cost-effective 
way to monitor high-risk subjects or as an evaluation measure 
in the development of new therapies.
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